Compare IFS & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IFS | TFX |
|---|---|---|
| Founded | 1897 | 1943 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.8B |
| IPO Year | 2014 | 1994 |
| Metric | IFS | TFX |
|---|---|---|
| Price | $57.79 | $127.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $48.00 | ★ $138.75 |
| AVG Volume (30 Days) | 373.1K | ★ 569.5K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.85% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | $7.38 | $5.15 |
| P/E Ratio | $9.61 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.39 | $100.18 |
| 52 Week High | $57.10 | $139.67 |
| Indicator | IFS | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 70.08 | 46.32 |
| Support Level | $43.65 | $124.49 |
| Resistance Level | N/A | $135.21 |
| Average True Range (ATR) | 1.96 | 3.44 |
| MACD | 0.76 | -0.51 |
| Stochastic Oscillator | 99.36 | 25.79 |
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.